POMC Deficiency
- 1 January 2025
- book chapter
- Published by Springer Nature
- p. 125-132
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Genetic Obesity Disorders: Body Mass Index Trajectories and Age of Onset of Obesity Compared with Children with Obesity from the General PopulationThe Journal of Pediatrics, 2023
- Heterozygous pathogenic variants in POMC are not responsible for monogenic obesity: Implication for MC4R agonist useGenetics in Medicine, 2023
- Aberrant expression of agouti signaling protein (ASIP) as a cause of monogenic severe childhood obesityNature Metabolism, 2022
- Understanding the Patient Experience of Hunger and Improved Quality of Life with Setmelanotide Treatment in POMC and LEPR DeficienciesAdvances in Therapy, 2022
- Long-term outcomes of bariatric surgery in patients with bi-allelic mutations in the POMC, LEPR, and MC4R genesSurgery for Obesity and Related Diseases, 2021
- Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trialsThe Lancet Diabetes & Endocrinology, 2020
- The mutational constraint spectrum quantified from variation in 141,456 humansNature, 2020
- Genetic Obesity and Bariatric Surgery Outcome in 1014 Patients with Morbid ObesityObesity Surgery, 2019
- POMC: The Physiological Power of Hormone ProcessingPhysiological Reviews, 2018
- Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humansNature Genetics, 1998